RA Capital Management
Status
ACTIVE
Global HQ
Boston, United States
Countries of investment
- United States
- United Kingdom
- China
- Switzerland
- Canada
- Denmark
- France
- Germany
- Italy
Investment stages
- Series A
- Series B
- Series C
- Growth
Industries
- Biotechnology
- Life Sciences
- Healthcare
- Pharmaceuticals
About
RA Capital Management advances evidence-based investing across public and private healthcare and life sciences, managing $12.6B in assets to fund novel therapies from early-stage biotech to clinical programs, leveraging integrated scientific diligence, data-driven analysis, and a long-term perspective on breakthrough patient impact.
RA Capital Management advances evidence-based investing across public and private healthcare and life sciences, managing $12.6B in assets to fund novel therapies from early-stage biotech to clinical programs, leveraging integrated scientific diligence, data-driven analysis, and a long-term perspective on breakthrough patient impact.
Investment Thesis
RA Capital Management drives life sciences innovation by funding breakthrough biotechnology, therapeutics, and healthcare platforms, combining deep scientific expertise with rigorous research and collaborative capital deployment.
Manager's Experience
Managed by life sciences investors and scientists with deep expertise in biotechnology, drug development, and healthcare innovation across public and private markets.
Team
Peter Kolchinsky - Managing Partner
Rajeev Shah - Managing Partner
Derek DiRocco - Partner
Matthew Hammond - Partner
Jeremy Lack - Partner
Andrew Levin - Partner
Josh Resnick - Partner
Jake Simson - Partner
Laura Stoppel - Partner
Mario Barro - Head of Infectious Disease Team
Portfolio
Moderna
Beam Therapeutics
Relay Therapeutics